kidney disease and semaglutide Separate combined effects of and empagliflozin on oxygenation and perfusion in people with type 2 diabetes: a randomised trial | Diabetologia Patients with type 2 #diabetes

Of 41 792 patients who discontinued and had a discontinuation weight measurement available, 1-year reinitiation was lower for those without type 2 diabetes (36.3% [95% CI, 35.6%-37.0%]) compared with those with type 2 diabetes (47.3% [95% CI, 46.6%-48.0%])

This reflects the chronic nature of metabolic regulation, not a harmful effect of the medication itself

Medi-Cal does not cover compounded semaglutide from 503A pharmacies, so using a compounding source means forgoing insurance altogether

PMID: 35 WaliaVPrickettTDKimJ-SGartnerJJLinJCZhouMet al

If you choose oral supplementation, standard doses range from 2501,500 mg daily